Invesco’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$446K Sell
130,512
-25,839
-17% -$80.3K ﹤0.01% 3290
2026
Q1
$356K Buy
156,351
+28,328
+22% +$65.2K ﹤0.01% 3281
2025
Q4
$358K Buy
128,023
+18,342
+17% +$65.6K ﹤0.01% 3322
2025
Q3
$526K Sell
109,681
-1,778,867
-94% -$11.3M ﹤0.01% 3212
2025
Q2
$17.2M Buy
1,888,548
+171,653
+10% +$1.26M ﹤0.01% 1508
2025
Q1
$15.5M Buy
1,716,895
+285,060
+20% +$3.01M ﹤0.01% 1558
2024
Q4
$18.7M Sell
1,431,835
-250,209
-15% -$3.34M ﹤0.01% 1522
2024
Q3
$26.4M Buy
1,682,044
+102,521
+6% +$1.55M 0.01% 1332
2024
Q2
$21.3M Buy
1,579,523
+422,116
+36% +$8.64M ﹤0.01% 1411
2024
Q1
$32.1M Buy
1,157,407
+1,809
+0.2% +$40.2K 0.01% 1230
2023
Q4
$22.3M Buy
1,155,598
+74,138
+7% +$1.34M 0.01% 1349
2023
Q3
$17.5M Buy
1,081,460
+115,995
+12% +$2.06M ﹤0.01% 1411
2023
Q2
$18.4M Sell
965,465
-303,662
-24% -$5.42M ﹤0.01% 1415
2023
Q1
$18.5M Sell
1,269,127
-180,785
-12% -$3.24M 0.01% 1393
2022
Q4
$28.3M Buy
1,449,912
+55,786
+4% +$1.09M 0.01% 1185
2022
Q3
$33.6M Buy
1,394,126
+49,476
+4% +$1.52M 0.01% 1059
2022
Q2
$42.3M Buy
1,344,650
+92,401
+7% +$3.35M 0.01% 989
2022
Q1
$55.1M Buy
1,252,249
+20,906
+2% +$898K 0.01% 966
2021
Q4
$53.6M Buy
1,231,343
+30,432
+3% +$1.19M 0.01% 1013
2021
Q3
$37.6M Sell
1,200,911
-465,193
-28% -$18.3M 0.01% 1175
2021
Q2
$70.5M Buy
1,666,104
+429,971
+35% +$16.7M 0.02% 944
2021
Q1
$46.5M Sell
1,236,133
-6,777
-0.5% -$212K 0.01% 1090
2020
Q4
$33.6M Buy
1,242,910
+207,137
+20% +$5.33M 0.01% 1181
2020
Q3
$26M Sell
1,035,773
-31,630
-3% -$461K 0.01% 1176
2020
Q2
$8.13M Sell
1,067,403
-146,827
-12% -$1.07M ﹤0.01% 1749
2020
Q1
$11.1M Sell
1,214,230
-189,548
-14% -$1.14M ﹤0.01% 1485
2019
Q4
$7.26M Sell
1,403,778
-18,093
-1% -$116K ﹤0.01% 1938
2019
Q3
$8.26M Sell
1,421,871
-983,002
-41% -$4.41M ﹤0.01% 1834
2019
Q2
$7.7M Buy
2,404,873
+1,432,480
+147% +$4.89M ﹤0.01% 1920
2019
Q1
$3.99M Sell
972,393
-3,875,345
-80% -$24.5M ﹤0.01% 2163
2018
Q4
$30.7M Buy
4,847,738
+2,189,038
+82% +$22.7M 0.01% 956
2018
Q3
$43.9M Buy
2,658,700
+404,482
+18% +$6.87M 0.01% 909
2018
Q2
$37.7M Buy
2,254,218
+348,302
+18% +$5.64M 0.01% 949
2018
Q1
$29.6M Buy
1,905,916
+442,825
+30% +$7.9M 0.01% 971
2017
Q4
$27.6M Buy
1,463,091
+299,501
+26% +$6.64M 0.01% 1043
2017
Q3
$34M Buy
1,163,590
+174,690
+18% +$5.16M 0.01% 936
2017
Q2
$31.8M Buy
988,900
+110,683
+13% +$3.63M 0.01% 990
2017
Q1
$30.4M Buy
878,217
+817,052
+1,336% +$29.2M 0.01% 1012
2016
Q4
$2.16M Sell
61,165
-225,630
-79% -$7.62M ﹤0.01% 2517
2016
Q3
$9.96M Buy
286,795
+9,225
+3% +$323K ﹤0.01% 1516
2016
Q2
$10.4M Buy
277,570
+60,831
+28% +$2.29M ﹤0.01% 1419
2016
Q1
$8.76M Buy
216,739
+75,635
+54% +$2.82M ﹤0.01% 1495
2015
Q4
$5.08M Buy
141,104
+16,603
+13% +$601K ﹤0.01% 1899
2015
Q3
$3.98M Sell
124,501
-1,382
-1% -$47K ﹤0.01% 2032
2015
Q2
$4.28M Buy
125,883
+24,880
+25% +$838K ﹤0.01% 2109
2015
Q1
$3.42M Buy
101,003
+46,473
+85% +$1.62M ﹤0.01% 2253
2014
Q4
$1.91M Sell
54,530
-20,818
-28% -$701K ﹤0.01% 2549
2014
Q3
$2.47M Sell
75,348
-4,787
-6% -$163K ﹤0.01% 2409
2014
Q2
$2.72M Sell
80,135
-1,984
-2% -$68K ﹤0.01% 2379
2014
Q1
$2.88M Buy
82,119
+5,522
+7% +$195K ﹤0.01% 2321
2013
Q4
$2.8M Sell
76,597
-17,529
-19% -$643K ﹤0.01% 2435
2013
Q3
$3.26M Buy
94,126
+13,839
+17% +$484K ﹤0.01% 2206
2013
Q2
$2.72M Buy
+80,287
New +$2.66M ﹤0.01% 2192

Other funds holding ACH

Invesco's ACH Position: Q2 2026 in Review

Invesco reduced its Accendra Health (ACH) stake by 17% in Q2 2026, selling an estimated $80.3K and leaving 130,512 shares worth $446K. The position accounts for ﹤0.01% of the portfolio, ranked #3290.

Invesco first reported a position in ACH in Q2 2013 and has held it in 53 quarters since. The position peaked at $70.5M in Q2 2021. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • Invesco held 130,512 shares of Accendra Health worth $446K as of Q2 2026.
  • Invesco sold 25,839 Accendra Health shares in Q2 2026, an estimated $80.3K.
  • Accendra Health made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3290 holding.
  • Invesco first reported a position in Accendra Health in Q2 2013 and has held it in 53 quarters since.
  • Invesco's Accendra Health position peaked at $70.5M in Q2 2021.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.